Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue

Moderna (NASDAQ: MRNA) reported Q1 EPS of ($3.40), $1.38 worse than the analyst estimate of ($2.02). Revenue for the quarter came in at $389 million versus the consensus estimate of $251.76 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• 8x8 reports data breach via third-party Salesforce integration
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance